v3.26.1

Variable Interest Entity (Details) - USD ($) |  |  | 1 Months Ended | 12 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | --- | ---
Dec. 31, 2021 | Dec. 30, 2021 | Dec. 31, 2021 | Dec. 31, 2025 | Dec. 31, 2024 | Nov. 30, 2024 | Mar. 31, 2023
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Variable interest primary beneficiary (in Dollars) |  |  |  | $ 61,873 | $ 691,253 |  |
Libra [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Voting right percentage |  |  |  | 48.33% |  |  |
Mios [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Voting right percentage |  |  |  | 48.39% |  |  |
Scipio [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Voting right percentage |  |  |  | 48.36% |  |  |
Class A Ordinary Shares [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Common stock voting rights |  |  |  | one |  |  |
Share of economic (in Shares) |  | 1 |  |  |  |  |
Ordinary shares (in Shares) |  |  |  | 6,346,823 | 3,811,823 |  | 70,430
Class A Ordinary Shares [Member] | Scipio [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Ordinary shares (in Shares) |  |  |  |  |  | 10,000 |
Class B Ordinary Shares [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Common stock voting rights |  |  | 10 | ten |  |  |
Share of economic (in Dollars per share) |  | $ 0.001 |  |  |  |  |
Ordinary shares (in Shares) |  |  |  | 1,796,934 | 1,796,934 |  |
Class B Ordinary Shares [Member] | Scipio [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Ordinary shares (in Shares) |  |  |  |  |  | 5,850,000 |
Libra Sciences Limited [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Ownership interest percentage | 97.27% |  | 97.27% |  |  |  |
Libra Sciences Limited [Member] | Group’s Subsidiaries [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Voting right percentage | 31.51% |  |  |  |  |  |
Libra Sciences Limited [Member] | Class A Ordinary Shares [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Common stock voting rights |  | 1 |  |  |  |  |
Libra Sciences Limited [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Common stock voting rights |  | 10 |  |  |  |  |
Mios Pharmaceuticals Limited [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Ownership interest percentage | 97.93% |  | 97.93% |  |  |  |
Mios Pharmaceuticals Limited [Member] | Group’s Subsidiaries [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Voting right percentage | 36.17% |  |  |  |  |  |
Scipio Life Sciences Limited [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Ownership interest percentage | 97.93% |  | 97.93% |  |  |  |
Scipio Life Sciences Limited [Member] | Group’s Subsidiaries [Member] |  |  |  |  |  |  |
Variable Interest Entity [Line Items] |  |  |  |  |  |  |
Voting right percentage | 35.06% |  |  |  |  |  |

X
- Definition Per share amount of economic benefit. + References No definition available. + Details
Name: | apm_ShareOfEconomic
Namespace Prefix: | apm_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Share of economic. + References No definition available. + Details
Name: | apm_ShareOfEconomicBenefit
Namespace Prefix: | apm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_CommonStockVotingRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 860 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (b)(1)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 860 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (b)(1)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 860 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A + Details
Name: | us-gaap_VariableInterestEntityLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A + Details
Name: | us-gaap_VariableInterestEntityOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of maximum exposure to loss from involvement with consolidated variable interest entity (VIE). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A + Details
Name: | us-gaap_VariableInterestEntityPrimaryBeneficiaryMaximumLossExposureAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=apm_LibraMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=apm_MiosMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=apm_ScipioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=apm_ScipioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_LibraSciencesLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=apm_GroupsSubsidiariesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_MiosPharmaceuticalsLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=apm_ScipioLifeSciencesLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |